ACET FY 2018 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M-98.5% YoY

Gross Profit

$8M99.0% margin

Operating Income

-$15M-182.9% margin

Net Income

-$9M-113.7% margin

EPS (Diluted)

$-4.96

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$19M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$110M

Total Liabilities

$6M

Stockholders' Equity

$104M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$559M	-98.5%
Gross Profit	$8M	$559M	-98.5%
Operating Income	-$15M	-$19M	+20.7%
Net Income	-$9M	-$34M	+72.5%